What is the real-world experience with daraxonrasib for metastatic pancreatic cancer, and how do patients tolerate it
Ask Navis about your situation
This answer is general. Get one about your specific case. No signup, answered right here.
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Sources & medical oversight
- Grounded in NCCN Guidelines for Patients: Pancreatic Cancer — the same guidelines oncologists use.
- Built by OpenCancer’s team of physician-scientists and cancer survivors.
- Last updated October 8, 2026. Informational only — not a substitute for your oncology team.
Daraxonrasib for Metastatic Pancreatic Cancer: What We Know
I appreciate your question, but I need to be direct with you: I don't have reliable real-world clinical data or patient tolerance information about daraxonrasib specifically for pancreatic cancer from the authoritative medical sources I'm designed to reference.
What I Can Tell You
Here's what's important to understand:
Current Status:
- Daraxonrasib is a relatively newer agent being studied in cancer research
- I cannot find this drug listed in the current NCCN Guidelines for Pancreatic Cancer (2025) as an established treatment option for metastatic pancreatic cancer
- Without it being in major clinical guidelines, I don't have validated safety and efficacy data to share with you
Why This Matters: According to the NCCN Guidelines, treatment decisions for metastatic pancreatic cancer are based on established therapies with proven clinical benefit. The guidelines emphasize that your care team should recommend treatments supported by clinical evidence and FDA approval status.
What You Should Do
Questions to ask your oncology team:
- "Is daraxonrasib FDA-approved for pancreatic cancer, or is it being used in a clinical trial?" (This tells you the evidence status)
- "What clinical data supports using this drug for my specific situation?"
- "Are there published studies on how patients tolerate this medication?"
- "How does this compare to standard treatment options for my stage of cancer?"
- "If this is a clinical trial, what are the potential benefits and risks?"
Finding Current Information
For the most up-to-date information on newer agents:
- Ask your oncologist about ClinicalTrials.gov to see if daraxonrasib studies are enrolling
- Request information from your cancer center's research team
- Contact the National Cancer Institute (NCI) at 1-800-4-CANCER for current treatment information
Your oncology team will have access to the latest clinical trial data and real-world experience that I cannot provide.
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
Ask Navis about your case
That answer is general. Ask about your specific situation. No signup, answered right here.
Facing this with someone you love?
Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.
Start a care circle →Source Guidelines
NCCN Guidelines for Patients: Pancreatic Cancer (2026)Browse all NCCN Guidelines for Patients →Have your records handy? Upload them for a deeper, personalized analysis →